Quick answer
A legitimate GHK-KPV listing documents two peptides, not one: GHK-Cu and KPV each need their own identity and purity evidence, plus a stated composition for the blend.
- What it is: a combination of the copper-binding tripeptide GHK-Cu and the tripeptide KPV, which is a different product from standalone KPV
- Documentation to require: per-component HPLC purity (≥98% as a buyer's threshold), per-component mass confirmation, lot-specific COA
- V8 listing: GHK-Cu + KPV, 60 mg lyophilized blend, ≥98% HPLC purity
- Red flag: one combined purity figure with no per-compound breakdown or ratio
- Research use: For laboratory research use only; not for human consumption.
What you are actually sourcing
For laboratory research use only; not for human consumption.
GHK-KPV combines two structurally unrelated research peptides, the copper-binding tripeptide GHK-Cu and the tripeptide fragment KPV, into a single formulation. That combination is convenient for labs studying both compounds in the same experimental context, but it also means the sourcing bar is effectively doubled: a supplier needs to verify identity and purity for two separate molecules, not one, and a vague "combination peptide" listing that skips per-compound data is a much bigger gap than it would be for a single-peptide product.
| Component | Sequence / class | Approximate mass | Research context |
|---|---|---|---|
| GHK-Cu | Gly-His-Lys complexed with copper(II) | ≈ 340 Da as free GHK; the complex is heavier by the copper | Copper-peptide signaling, dermal extracellular-matrix models |
| KPV | Lys-Pro-Val, the C-terminal tripeptide of alpha-MSH | ≈ 342 Da | Melanocortin-related inflammation-signaling models |
Both are very small peptides, which is useful to know when reading analytical documentation: they elute early on reversed-phase HPLC and, at nearly the same mass, are easy to confuse unless retention time and mass are both reported. The V8 product page summarizes the blend's research applications as copper-peptide signaling, melanocortin (KPV) anti-inflammatory models and dermal extracellular-matrix research.
Why a blend needs more documentation, not less
Some suppliers regard blended products as a shortcut: a single purity percentage and a single COA covering "the blend" as though it were one substance. That is not sufficient for a genuine two-peptide product. GHK-Cu and KPV have different molecular weights, different synthesis considerations and different degradation profiles. A COA for a real blend should verify:
- GHK-Cu identity and purity independently, via HPLC and mass spectrometry.
- KPV identity and purity independently, via the same methods.
- The stated ratio of the two compounds in the formulation, since an off-ratio blend changes the experimental conditions even if both individual peptides are pure.
If a listing provides only a single combined purity figure with no per-compound breakdown, regard that as incomplete documentation rather than a simplified summary. See how to read a COA for what a complete certificate should contain. A related point on the analytical side: under the acidic mobile phases used in reversed-phase HPLC, copper typically dissociates from GHK-Cu, so the chromatogram shows free GHK. Copper content is a separate measurement, and a COA that says nothing about it is not wrong, but it also does not document the copper complex.
GHK-KPV vs. standalone KPV: not the same purchase
It is worth being explicit about a distinction that catches first-time buyers: GHK-KPV (the GHK-Cu/KPV combination) is a different product from standalone KPV, which V8 Peptides also carries separately. Researchers studying the melanocortin-pathway effects associated with KPV specifically, without the copper-peptide component, should order the standalone KPV product rather than the blend. Likewise, a lab that needs GHK-Cu alone should look at the GHK-Cu copper peptide listing.
| Research question | Better-fitting product type | Why |
|---|---|---|
| Effect of KPV alone | Standalone KPV | No confounding copper-peptide component |
| Effect of GHK-Cu alone | Standalone GHK-Cu | No confounding second peptide |
| Combined presence of both in one preparation | GHK-Cu + KPV blend | Fixed composition, one vial to reconstitute |
| Varying the ratio between the two | Two separate single-peptide products | A pre-mixed blend has a fixed ratio |
The Where to Buy KPV guide covers sourcing considerations specific to the standalone compound, including how it differs from the closely related alpha-MSH fragment; see KPV vs. alpha-MSH for that comparison, and what is KPV for the basics.
Purity and identity thresholds to require
- 98%+ HPLC purity for each individual peptide component, not just the blend as a whole.
- Mass spectrometry confirmation for both GHK-Cu and KPV, verifying that the molecular weight matches the expected value for each.
- Lot-specific documentation tied to the batch number on the vial you actually received, not a generic product sheet.
- Stated composition: milligrams of each component per vial, or the ratio, so concentrations of each can be calculated.
For background on why HPLC and mass spec check different things and neither substitutes for the other, see HPLC vs. mass spectrometry and understanding HPLC purity. The composition point matters for lab arithmetic: a 60 mg vial reconstituted in 3 mL of diluent is 20 mg/mL of combined material, but the concentration of GHK-Cu or KPV alone depends on the blend ratio. The reconstitution calculator handles the volume math once that ratio is known.
Packaging, stability and handling
GHK-Cu's copper-chelate structure and KPV's short peptide sequence both tolerate lyophilized storage well, but the combination should still arrive as a sealed, properly labeled vial with no visible moisture exposure. Reconstituted liquid material should never be shipped at ambient temperature. The V8 product page lists a sealed clear glass research vial and recommends storage at 2–8 °C, or −20 °C for long-term, protected from heat, moisture and light. See the GHK-KPV research overview for compound-level context, and how research peptides are shipped for what to expect on arrival. Once opened, handle the vial following storing research peptides.
One practical observation: copper-containing solutions can be intensely blue, and a visibly colored reconstituted blend is expected for GHK-Cu and is not by itself a sign of contamination. Cloudiness or particulates are a different matter; cloudy peptide vial after reconstitution explains how to interpret them.
Third-party verification matters more here, not less
Because a blended product gives a supplier more places to cut corners (wrong ratio, an unverified second component, documentation reused from the standalone products), independent testing is a stronger signal for combination products than for single-compound ones. A self-generated COA from the supplier's own instrument carries an inherent conflict of interest; a third-party lab result does not. See third-party testing explained for what to look for in an independent lab report, and vetting a research peptide supplier for a broader framework.
Red flags specific to blended products
- A single purity number for "the blend" with no per-compound breakdown.
- No stated ratio of GHK-Cu to KPV in the formulation.
- A COA that appears identical across unrelated blend products, suggesting a template rather than lot-specific data.
- Pricing that does not reflect two separately synthesized and purified peptides.
- A listing that never mentions that standalone KPV and GHK-Cu exist as distinct products.
More general warning signs are collected in red flags when buying research peptides.
What V8 Peptides states on the listing
The V8 GHK-Cu + KPV page describes a 60 mg lyophilized blend of GHK-Cu and KPV at ≥98% HPLC purity, with batch-specific analytical documentation published on the V8 site. The listing notes that identity and sequence information is reported on the certificate of analysis where published, so the lot you hold should be checked against the COA page before it is used in an experiment, using the per-component criteria above. All research peptides on V8 Peptides are sold strictly for laboratory research use. For a general framework that applies across the catalog, see choosing a peptide supplier, and for testing detail specific to this blend see GHK-KPV purity testing.
Research Use Only. For laboratory research use only; not for human consumption. Not for veterinary or diagnostic purposes. This article is research education, not usage guidance.
Where to buy GHK-KPV: FAQ
Is GHK-KPV the same as KPV?
No. GHK-KPV here refers to a blend of GHK-Cu and KPV. Standalone KPV is a separate product and is the better fit for work on KPV alone.
What documentation should a two-peptide blend have?
A lot-specific COA with identity and purity for each peptide, a mass spectrometry result for each, and a stated ratio or composition.
Why is one combined purity number not enough?
It can hide a weak component. A blend can average 98% while one peptide is substantially less pure, so per-component figures are needed.
Why does GHK-Cu appear as GHK on a chromatogram?
Acidic reversed-phase conditions typically strip copper from the complex, so the analysis observes the free tripeptide. Copper content needs a separate measurement.
What size and purity does V8 list for GHK-Cu + KPV?
The product page lists a 60 mg lyophilized blend with ≥98% HPLC purity.
How do I check the lot I received?
Match the lot number on the vial to the certificate, and look up records on the COA page.
Can I work out the concentration of each peptide after reconstitution?
Only if the composition is known. Total concentration is mg ÷ mL of diluent; each peptide's share depends on the blend ratio, which should be on the documentation.
Is a blue solution a problem?
Not by itself. Copper(II)-peptide complexes are naturally blue in solution. Cloudiness or particles are the signs that warrant investigation.